What Critics Get Right

Nine arguments are made against this approach with any regularity. Each is set out below in the form a serious critic would make it, followed by a verdict.

The verdicts are not evenly distributed. Five are conceded outright. Where an argument is conceded, nothing follows it, because a concession with a rebuttal attached is not a concession.

6. The terminology overstates what the owner controls

The argument, in the critics' own words. The phrase becoming your own banker, taken from the title of Nelson Nash's book and a registered trademark of Infinite Banking Concepts, LLC, promises something a contract cannot deliver.

Language in this field implies operating an institution and independence from the financial system. What is owned is a contract with an insurer, administered by the insurer under its terms.

Verdict: partly conceded. The criticism of the language is correct and the marketing in this field earns it. The limit is that the underlying feature is real: a contract does permit the owner to request a loan against value without a credit assessment, on terms fixed by the contract rather than by a lender's appetite that year. That is a genuine difference in access. It is not independence, and it should not be described as if it were.

7. Illustrations are treated as forecasts

The argument. A document showing values decades out is arithmetic under assumptions. Dividend scales move. Presenting a projection as an expectation misleads whether or not anyone intends it.

Verdict: partly conceded. The misuse is real and common. The limit is that an illustration also contains a guaranteed column, which is contractual and does not depend on any assumption. The failure is in showing only the illustrated column, not in the existence of illustrations. Ask for both.

8. Policies are sold to people who should not have them

The argument. Compensation is paid at issue while suitability depends on decades of stable cash flow. Those two facts create pressure in one direction.

Verdict: partly conceded. The incentive is real and is disclosed on the author page. The limit is that the same structure exists across advised financial products, and the answer is a suitability test the buyer can apply themselves, which is why the failure modes names who carries the most risk rather than leaving it general.

9. The tax advantages are overstated

The argument. Most versions of this argument come from the United States and reason from the modified endowment contract rules, or from section 7702 of the US Internal Revenue Code, to conclude that the tax treatment is narrower than claimed.

Verdict: rejected, for Canada. Not because the caution is unwarranted, but because those rules do not govern a Canadian contract. The Canadian test is whether a contract remains exempt under Regulation 306, Income Tax Regulations, and a policy loan is a disposition under ITA s.148(9). A Canadian reader applying the American analysis is being warned about rules that do not apply and reassured about none of the rules that do.

This is the one place where imported criticism genuinely misleads, and it misleads in both directions.

What the tally means

Five conceded, three partly conceded, one rejected on jurisdiction.

That is not a defence of the product. It is a narrower claim: the product is narrower than its marketing suggests, suits fewer people than are shown it, and is criticised most effectively by people who have understood it. A reader who has absorbed all nine arguments is better placed to evaluate a presentation than one who has only heard the case in favour.

A participating whole life contract is an insurance product and it is not an investment. Most of the criticism above is what happens when it is sold as something else.

Three arguments that are made and are simply wrong

Included because a page claiming to weigh criticism honestly has to say where the criticism fails, not only where it lands.

"It is a scam." No recruitment structure, no return funded by later entrants, no unregistered instrument. A participating contract is issued by a supervised insurer under provincial legislation with terms in a document you read before signing. The word describes fraud, and applying it to a regulated contract makes the genuine criticisms easier to dismiss.

"The insurance company keeps your cash value when you die." Stated frequently and it misdescribes the arrangement. What is paid on death is the death benefit, which is larger than the cash value in any ordinary contract. The cash value is not a separate account withheld; it is a value within the same contract the benefit is paid under. The contract settles it at maturity: a policy written to age 100 endows there, and in the guaranteed column the cash value and the death benefit at age 100 are the same figure. They converge because they were always converging on the same thing, and an illustration truncated before maturity removes the row that proves it. Whether the total is good value is a fair question. This particular framing is not.

"You can do better with buy term and invest the difference." Sometimes true, and stated as a universal it assumes the difference is actually invested, that it stays invested through a downturn, that the term coverage is replaced when it expires, and that the person remains insurable. Those four assumptions frequently fail, and a comparison assuming all four holds is comparing a disciplined ideal against a real product.

Why saying this matters. A page that concedes everything is not more honest than one that concedes nothing; it is simply less useful. The nine arguments above are conceded or partly conceded because they are correct, and these three are rejected because they are not.

What a critic and a practitioner would both agree on

A shorter list than either side admits, and worth stating because it is where a reader can stand.

The costs are front-loaded and early exit is expensive. Dividends are not guaranteed. Most households should use registered contribution room first. Illustrations are projections and are routinely misused. The product requires a horizon measured in decades. And it is sold to people who should not have it.

Six statements, all agreed on both sides. A reader who holds only those is better equipped than one who has read either side's full case, and that is an uncomfortable thing for a practice to publish.

Why a practice publishes a list of concessions

Nine criticisms, most conceded, on a site belonging to a practice that places these contracts. The reason should be stated rather than left to be inferred.

Because they are true. A page omitting them is inaccurate by silence, which is the same failure as inaccuracy by statement and harder to detect.

Because the reader will meet them anyway, usually presented at their strongest by someone with the opposite commercial interest, and without the three that are wrong separated out. Meeting them here first is better for the reader.

Because a practice unwilling to state them has told you what its description of the benefits is worth. A description that concedes nothing is advertising whatever its tone.

And because the criticisms are the specification. Read carefully, this page is a list of the ways this product is mis-sold: the wrong comparison, the undisclosed cost, the front-loaded exit risk, the displaced registered room, the overstated terminology, the illustration read as a forecast, the unsuitable buyer. A practice that avoids all nine is doing the job properly, and a reader holding the list can check whether it has.

How to use this list when somebody is selling to you

Ask which of the nine applies to what you are being shown. An honest answer names at least one, because at least one always applies.

Ask for the guaranteed column, which answers points 3, 4 and 7 at once.

Ask whether registered room is being displaced, which answers point 5.

Ask what the interest on an advance does and where it goes, which answers point 2 and separates a practitioner who understands the mechanics from one repeating a phrase.

Ask who should not buy this, which answers point 8. An honest answer arrives quickly and names categories.

Five questions. None requires technical knowledge, all are answerable from the contract and the illustration, and the reaction to them is as informative as the answers.

What none of the nine establishes

Worth stating, because a list of concessions can be read as a verdict and it is not one.

None of them shows the product does not work. They show it is expensive as a growth vehicle, unforgiving of early exit, opaque on cost, and frequently mis-sold. A product can be all four and still be right for a particular household, which is what suitability means.

None of them addresses the death benefit, which is the thing actually being bought and which no portfolio provides.

And none of them is an argument about you. Every criticism here is general. Whether any applies to your situation depends on facts this page does not have, and that is the question the criticisms exist to help you ask rather than answer.

What a practitioner would concede in private

Worth writing down, because these are the things said in advisor conversations and rarely in marketing.

The first-year numbers are hard to defend to a new client, and every practitioner knows it. The usual response is to direct attention to year twenty.

Most illustrations are shown at the current scale only, because the lower scenario is less persuasive, even though the insurer prints it as standard.

A meaningful share of contracts written do not survive ten years, and the households that surrender are worse off than if nothing had been arranged.

Compensation weighted to the first year shapes behaviour, and pretending it does not is the least credible thing this industry says.

None of that makes the product wrong. It makes the distribution the weak point, which is what the eighth criticism above already says and which practitioners generally accept privately.

What this list is for

Not to talk you out of the product. Five of the criticisms stand and the product still suits some households.

To let you test what you are shown. Each item is a way this product is mis-sold, and a presentation avoiding all nine is doing the job properly.

And to make the concessions before somebody else does, because a criticism first met from a competitor lands harder than one already conceded.

What to do with this page

Take it into the next conversation.

Ask which of the nine applies. Ask for the guaranteed column. Ask who should not buy it. The answers, and the willingness to give them, tell you more than any illustration.

And notice what happens when you ask. A practitioner who concedes readily is describing a product. One who concedes nothing is selling one, and the difference is audible within a minute of asking.

The willingness to concede is the signal. Not because concession proves competence, but because a description that admits its own weaknesses has told you what it is, and one that admits none has told you what it is doing. Both are informative and only one is useful, and you can establish which within the first few minutes of any conversation about this product.

Ask early. The concession, or its absence, arrives in the first few minutes and costs nothing to find out. A conversation that begins with what the product does badly is one that can be trusted about what it does well.

It is the cheapest diligence available anywhere in this subject.

What this page will not do

It will not use a list of concessions as a credibility device and then arrive at a recommendation.

Publishing criticism is a well-known way to appear trustworthy immediately before asking for something. This page ends here, with no next step and no invitation, because a page whose entire purpose is honesty about the arguments against should not close by selling.